A recent report was made from Chicago Tribune concerning Eric Lefkofsky’s firm, Tempus, receiving $80 million in funding from an existing and new group of investors. And as a result, Tempus has achieved a status of a unicorn. Since its establishment in 2015, Tempus has raised investments amounting to $210 million. With this last round of funding, the value of Tempus is now reportedly worth approximately $1.1 billion, thus, giving the company the unicorn status. Only a few startups in Chicago can claim this.
According to Lefkofsky, his company now has approximately 400 employees, and they are adding around 30 employees each month. He also stated that the additional funding is expecting to add even more employees.
Lefkofsky thinks that his company’s traction has been amazing being in the midst of a very important paradigm shift in this time period. Tempus is utilizing clinical data to collect molecular data of patients who undergo treatment as well as to find trends for overall cancer treatment. He is also proud of the fact that his company maintains relationships with organizations and individuals of all the areas of the health care system in which more effective treatments are being sought out through the use of big data for patients.
About Eric Lefkfosky
Being the Chief Executive Officer and co-founder of Tempus, Eric Lefkfosky is an American businessman who is originally from Southfield, Michigan, a suburb outside of Detroit, Michigan. He earned a bachelor of art degree from the University of Michigan in 1991 in which he graduated with honors. In 1993, he earned his Juris Doctorate degree from the University of Michigan Law School.
Tempus is a technology firm that fights against cancer through the use of genomic data. This company was formed after enduring the frustration of the health system, not utilizing valuable data that can significantly make a difference for cancer patients.
To Read More Click Here